Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
Crossref DOI link: https://doi.org/10.1186/s40779-016-0081-6
Published Online: 2016-04-27
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhao, Xin
Yang, Xiao-Xu
Ji, Su-Zhen
Wang, Xiao-Zeng
Wang, Li
Gu, Chong-Huai
Ren, Li-Li
Han, Ya-Ling